Myomo Announces Q2 Preliminary Revenue
BOSTON (July 7, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces preliminary second quarter revenue and provides an update on its pipeline entering the third quarter. Read more.
Myomo To Present at the Sidoti Summer Small Cap Virtual Investor Conference
BOSTON (June 9, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, Myomo’s chairman and chief executive officer, and David Henry, Myomo’s chief financial officer, will present and provide a […]
Myomo Reports First Quarter 2022 Financial Results
Revenue of $3.9 million up 66% over prior year, product revenue of $2.9 million up 23% Pipeline of 924 MyoPro candidates up 14% over fourth quarter of 2021 Conference call begins at 4:30 p.m. Eastern time today BOSTON (May 11, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics […]
Myomo to Report First Quarter Financial Results on May 11, 2022
BOSTON (May 4, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the three months ended March 31, 2022 on May 11, 2022 after the market […]
Myomo Reports Progress with China Joint Venture, Receives Partial Payment of Technology License Fee
BOSTON (April 4, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, provides an update on the status of its joint venture (“JV”) in China and the associated impact on first quarter 2022 revenue. As […]
Myomo To Participate in Two March Investor Conferences
BOSTON (March 9, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces that management will participate in two investor conferences during March. Read more.
Myomo Reports Fourth Quarter and Full Year 2021 Financial Results
Fourth quarter revenue of $4.0 million up 6% over prior year, full year revenue of $13.9 million up 83% over 2020 Fourth quarter gross margin of 77.4% up 400 basis points over prior year Conference call begins at 4:30 p.m. Eastern time today BOSTON (March 9, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or […]
Myomo to Report Fourth Quarter and Full Year 2021 Financial Results on March 9, 2022
BOSTON, Mass., (March 2, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the three months and fiscal year ended December 31, 2021 on March 9, […]
Myomo Strengthens Intellectual Property Portfolio with Receipt of Key Patent in Japan
Brings the total number of patents issued on the MyoPro® device globally to 20 BOSTON (February 17, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces the granting of patent number 6998478 titled “Powered […]
Independent Research with Myomo’s MyoPro® Shows Clinically Significant Gains in Motor Function in Individuals with Chronic Moderate-to-Severe Arm Weakness
Adds to Body of Evidence Supporting the Utility of MyoPro in Stroke and Traumatic Brain Injury Patients BOSTON (February 14, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces that new research measuring the […]